GENEVA, July 9 -- ARJIL BIOTECH HOLDING COMPANY LIMITED filed a patent application (US2025/061620) for “NEW OVATODIOLIDE DERIVATIVES EFFECTIVE FOR TREATING AUTOIMMUNE DISEASES”. With publication no. WO/2026/147978, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 493/02
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....